MINNEAPOLIS, Jan. 12, 2017 -- Skyline Medical Inc. (NASDAQ:SKLN) (“Skyline” or “the Company”), producer of the FDA-approved STREAMWAY® System for automated, direct-to-drain medical fluid disposal, announced today that management will hold a conference call on January 19, 2017 to provide a business update and a discussion on recent and upcoming milestones.
The conference call is scheduled to begin at 4:30 p.m. (Eastern Time).
To access the conference call, U.S.-based listeners should dial 844-666-7589 and international listeners should dial 443-961-0433. All listeners should provide the following passcode: 49910217.
Following the conclusion of the conference call, a replay will be available through January 25, 2017 and can be accessed by dialing (855) 859-2056 from within the U.S. or (404) 537-3406 from outside the U.S. All listeners should provide passcode 49910217.
About Skyline Medical Inc.
Skyline Medical Inc. produces a fully automated, patented, FDA-cleared, waste fluid disposal system that virtually eliminates staff exposure to blood, irrigation fluid and other potentially infectious fluids found in the healthcare environment. Antiquated manual fluid handling methods — which require hand carrying and emptying filled fluid canisters — present an exposure risk and potential liability. Skyline Medical's STREAMWAY System fully automates the collection, measurement and disposal of waste fluids and is designed to: 1) reduce overhead costs to hospitals and surgical centers, 2) improve compliance with OSHA and other regulatory agency safety guidelines, 3) improve efficiency in the operating room, and radiology and endoscopy departments — leading to greater profitability, and 4) provide greater environmental stewardship by helping to eliminate the approximately 50 million potentially disease-infected canisters that go into landfills annually in the United States. For additional information, please visit www.skylinemedical.com.
Contact: Investors LHA Kim Sutton Golodetz (212) 838-3777 [email protected] MoneyInfo, LLC Charles Moskowitz (781) 826-8882 [email protected]


Microsoft's $10 Billion Japan Investment: AI Infrastructure and Data Sovereignty Push
Russell 1000 Companies Hit $2.2T Cash Record While Aggressively Reinvesting in Growth
Fonterra Admits Anchor Butter "Grass-Fed" Label Misled Consumers After Greenpeace Lawsuit
Microsoft Eyes $7B Texas Energy Deal to Power AI Data Centers
Eli Lilly and Insilico Medicine Forge $2.75 Billion AI-Driven Drug Discovery Deal
RBC Capital: European Medtech Firms Show Minimal Middle East and Energy Risk Exposure
Norma Group Posts Revenue Decline in 2025, Eyes Modest Recovery in 2026
SpaceX Eyes Historic IPO at $1.75 Trillion Valuation
OpenAI Executive Shake-Up Ahead of Anticipated 2026 IPO
MATCH Act Targets ASML and Chinese Chipmakers in New U.S. Export Crackdown
Trump Administration Plans 100% Tariffs on Pharmaceutical Imports
Elon Musk Ties SpaceX IPO Access to Mandatory Grok AI Subscriptions
Star Entertainment Secures $390M Refinancing Deal to Stabilize Operations
Annie Altman Amends Sexual Abuse Lawsuit Against OpenAI CEO Sam Altman
KPMG UK Cuts 440 Audit Jobs Amid Low Attrition and Cooling Professional Services Demand
TSMC Japan's Second Fab to Produce 3nm Chips by 2028
First Western Ship Transits Strait of Hormuz Since Iran War Began 



